Oligocan Argent colloïdal
Natural health product licensed in Canada
- Other names
- Oligocan Colloidal Silver
- Licence holder
- Homeocan Inc.
- NPN or DIN-HM
- 80122402
- Status
- Active licence
- Licence date
- 16 December 2022
- Revision date
- Not provided
- Form
- Liquide oral
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Argent Source : Argent colloïdal | 15 ppm | Not calculated |
| Argent Source : Argent colloïdal | 0.075 mg | Not calculated |
Non-medicinal ingredients
Eau purifiée
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18 years | 1 Cuillère à café | 1 day |
Uses authorised in Canada
Oligo-élément. Source d'argent, un oligo-élément.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
L'accumulation d'argent (résultat d'un apport excessif sur une longue durée) peut mener à l'argyrie, une décoloration permanente bleutée ou grisâtre de la peau liée aux dépôt de granules de composés argentés dans les tissus conjonctifs. Cette condition persiste indéfiniment, ou disparaît très lentement.
- Précautions et mises en garde
Consulter un professionnel de la santé avant d'utiliser si vous avez un trouble du foie ou des reins. Consulter un professionnel de la santé si les symptômes persistent ou s'aggravent. La surutilisation peut réduire les niveaux de sélénium.
- Contre-indications
Ne pas utiliser si vous êtes enceinte ou si vous allaitez.
Source
Official Health Canada record, licence 80122402
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.